Spero Therapeutics Inc (SPRO)
1.615
+0.08
(+4.87%)
USD |
NASDAQ |
May 02, 16:00
1.615
0.00 (0.00%)
After-Hours: 16:28
Spero Therapeutics Free Cash Flow: -33.00M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -33.00M |
| September 30, 2023 | 28.98M |
| June 30, 2023 | 12.11M |
| March 31, 2023 | 7.639M |
| December 31, 2022 | -7.731M |
| September 30, 2022 | -79.56M |
| June 30, 2022 | -83.56M |
| March 31, 2022 | -77.09M |
| December 31, 2021 | -64.35M |
| September 30, 2021 | -53.38M |
| June 30, 2021 | -69.69M |
| March 31, 2021 | -78.02M |
| December 31, 2020 | -86.03M |
| Date | Value |
|---|---|
| September 30, 2020 | -87.13M |
| June 30, 2020 | -75.49M |
| March 31, 2020 | -62.74M |
| December 31, 2019 | -50.33M |
| September 30, 2019 | -48.76M |
| June 30, 2019 | -44.62M |
| March 31, 2019 | -38.59M |
| December 31, 2018 | -39.62M |
| September 30, 2018 | -38.86M |
| June 30, 2018 | -43.86M |
| March 31, 2018 | -44.09M |
| December 31, 2017 | -39.11M |
Free Cash Flow Range, Past 5 Years
-87.13M
Minimum
Sep 2020
28.98M
Maximum
Sep 2023
-50.14M
Average
-62.74M
Median
Mar 2020
Free Cash Flow Benchmarks
| Retractable Technologies Inc | 1.914M |
| OptiNose Inc | -20.86M |
| scPharmaceuticals Inc | -59.28M |
| electroCore Inc | -14.87M |
| Equillium Inc | -21.83M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -17.49M |
| Cash from Financing (Quarterly) | 0.001M |
| Free Cash Flow Per Share (Quarterly) | -0.3231 |
| Free Cash Flow to Equity (Quarterly) | -17.49M |
| Free Cash Flow to Firm (Quarterly) | -17.49M |
| Free Cash Flow Yield | -38.56% |